A detailed history of Rokos Capital Management LLP transactions in Eli Lilly & CO stock. As of the latest transaction made, Rokos Capital Management LLP holds 67,559 shares of LLY stock, worth $51.9 Million. This represents 1.0% of its overall portfolio holdings.

Number of Shares
67,559
Holding current value
$51.9 Million
% of portfolio
1.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$772.14 - $960.02 $52.2 Million - $64.9 Million
67,559 New
67,559 $59.9 Million
Q1 2024

May 15, 2024

BUY
$592.2 - $792.28 $47.7 Million - $63.8 Million
80,576 New
80,576 $62.7 Million
Q2 2021

Aug 16, 2021

SELL
$180.55 - $233.54 $36.5 Million - $47.2 Million
-202,164 Closed
0 $0
Q1 2021

May 13, 2021

BUY
$164.32 - $212.72 $33.2 Million - $43 Million
202,164 New
202,164 $37.5 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $730B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Rokos Capital Management LLP Portfolio

Follow Rokos Capital Management LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rokos Capital Management LLP, based on Form 13F filings with the SEC.

News

Stay updated on Rokos Capital Management LLP with notifications on news.